QoL improvements ID'd in phase 3 ARANOTE trial for mHSPC

Trastuzumab deruxtecan plus pertuzumab may delay cancer growth for some HER2-positive advanced breast cancers

Rusfertide shows promise for polycythemia vera treatment

Neoadjuvant gemcitabine and cisplatin improves OS in resectable biliary tract cancer

Cemiplimab reduces disease recurrence as adjuvant therapy for cutaneous squamous cell carcinoma

ASCO 2025: Update on blood-based cancer assays

Trastuzumab deruxtecan benefit for some advanced gastric cancers

HER2-positive breast cancer: Predicting pCR from clinicopathologic variables and genomic testing

Tumor Treating Fields plus chemo shows OS benefit in unresectable pancreatic cancer

Abemaciclib potential therapeutic option for Kaposi sarcoma

Making immune check point inhibitors for lung cancer cost-effective in LMICs

ASCO 2025: Latest in EGFR positive NSCLC